Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours

This is a phase I, open-label study to assess the safety, tolerability, pharmacokinetics(PK) and anti-tumour activity of adavosertib in Japanese patients with advanced solid tumours. This study

  • 0 views
  • 15 Jan, 2021
  • 1 location
A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

This Phase 2b study aims to evaluate the efficacy and safety of adavosertib, an inhibitor of the tyrosine kinase WEE1, in subjects with recurrent or persistent uterine serous carcinoma (USC) who

  • 0 views
  • 27 Dec, 2020
  • 42 locations
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian Fallopian Tube or Primary Peritoneal Cancer

This pilot early phase I trial studies how adavosertib affects the tumor deoxyribonucleic acid (DNA) of patients undergoing surgery for high grade (fast growing or aggressive) ovarian, fallopian

cancer
tubal ligation
tumor cells
copper
azd1775
  • 0 views
  • 25 Jan, 2021
  • 9 locations
Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian Primary Peritoneal or Fallopian Tube Cancer

This phase II trial studies how well adavosertib with or without olaparib work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that has come back (recurrent

olaparib
neutrophil count
metastasis
cancer
direct bilirubin
  • 8 views
  • 24 Jan, 2021
  • 1 location
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body (advanced/metastatic). Adavosertib may

gilbert's syndrome
neutrophil count
metastasis
direct bilirubin
kinase inhibitor
  • 37 views
  • 18 Jan, 2021
  • 19 locations
Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance STAR Study

This phase I trial studies the side effects and best dose of adavosertib when given together with olaparib in treating patients with solid tumors that have spread to other places in the body

olaparib
neutrophil count
metastasis
nervous
cancer
  • 0 views
  • 09 Dec, 2020